Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:785 (1 October), doi:10.1136/bmj.331.7519.785
| The first 150 words of the full text of this article appear below. |
In southern Africa, antiretroviral drugs are a late entrant in an already vibrant market for AIDS treatments. Traditional medicine does not treat HIV infection as such but does provide many supportive therapies. Whatever its credibility in the eyes of university trained doctors, the "neo-traditional" management of AIDS has gained a space in the market. Recognition of this economic reality could be important for the success of antiretroviral treatment.
In South Africa's central Free State province 30% of householders said they would recommend a traditional healer to manage AIDS, and only half had even heard of antiretrovirals. The low uptake of free antiretrovirals in countries such as Botswana should be another clue that the treatment is not an easy fix. Among other problems, people need to know and to accept their HIV status before they can receive treatment. The conditions for disclosure are not good in southern Africa, where the
Neil Andersson, executive director
CIET Trust, Saxonwold, South Africa neil@ciet.org